OQS
CRMD icon

Occudo Quantitative Strategies’s CorMedix CRMD Stock Holding History

Occudo Quantitative Strategies’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-74,763
Closed -$277K – 856
2023
Q3 		$277K Buy
74,763
+29,704
+66% +$118K 0.04% 693
2023
Q2 		$179K Buy
45,059
+17,126
+61% +$84.7K 0.02% 868
2023
Q1 		$116K Buy
+27,933
New +$114K 0.01% 807

Other funds holding CRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Occudo Quantitative Strategies's CRMD Position: Q4 2023 in Review

Occudo Quantitative Strategies sold out of CorMedix (CRMD) in Q4 2023, closing a stake of 74,763 shares — an estimated $277K sold.

Occudo Quantitative Strategies first reported a position in CRMD in Q1 2023 and held it in 3 quarters. The position peaked at $277K in Q3 2023. 101 funds tracked by Wall St. Rank hold CRMD as of Q4 2023.

  • Occudo Quantitative Strategies reported no remaining CorMedix position as of Q4 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 74,763 CorMedix shares in Q4 2023, an estimated $277K.
  • Occudo Quantitative Strategies first reported a position in CorMedix in Q1 2023 and held it in 3 quarters.
  • Occudo Quantitative Strategies's CorMedix position peaked at $277K in Q3 2023.
  • 101 funds tracked by Wall St. Rank held CorMedix as of Q4 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2023, filed 14 Feb 2024.